Ad
OMER Quote Trading Chart Omeros Corporation
home / stock / omer / omer quote
Quote | Omeros Corporation (NASDAQ:OMER)
| Last: | $8.49 |
|---|---|
| Change Percent: | 0.67% |
| Open: | $8.95 |
| Close: | $8.49 |
| High: | $9.29 |
| Low: | $8.3001 |
| Volume: | 1,020,933 |
| Last Trade Date Time: | 12/12/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
OMER Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $8.49 | $8.95 | $8.49 | $9.29 | $8.3001 | 1,020,933 | 12-12-2024 |
| $9.01 | $10.57 | $9.01 | $10.67 | $8.91 | 1,050,727 | 12-11-2024 |
| $10.54 | $11.13 | $10.54 | $11.59 | $10.51 | 583,101 | 12-10-2024 |
| $11.38 | $12 | $11.38 | $12.12 | $11.26 | 319,123 | 12-09-2024 |
| $11.61 | $11.06 | $11.61 | $12.65 | $11.06 | 962,662 | 12-06-2024 |
| $11.1 | $11.62 | $11.1 | $11.79 | $10.99 | 399,465 | 12-05-2024 |
| $11.68 | $11.01 | $11.68 | $11.71 | $10.86 | 502,051 | 12-04-2024 |
| $11.06 | $11.94 | $11.06 | $12.2403 | $10.62 | 854,801 | 12-03-2024 |
| $11.95 | $11.22 | $11.95 | $12.105 | $11.0316 | 862,159 | 12-02-2024 |
| $11.35 | $11.98 | $11.35 | $11.98 | $11.01 | 692,380 | 11-29-2024 |
| $11.91 | $11.89 | $11.91 | $12.255 | $11.27 | 1,040,130 | 11-28-2024 |
| $11.91 | $11.89 | $11.91 | $12.255 | $11.27 | 1,040,130 | 11-27-2024 |
| $12.15 | $11.8 | $12.15 | $12.49 | $11.26 | 1,598,691 | 11-26-2024 |
| $11.79 | $11 | $11.79 | $11.82 | $10.34 | 2,107,084 | 11-25-2024 |
| $10.91 | $7.7 | $10.91 | $10.99 | $7.4597 | 4,068,706 | 11-22-2024 |
| $7.73 | $6.09 | $7.73 | $7.85 | $6.06 | 1,632,002 | 11-21-2024 |
| $6.03 | $6 | $6.03 | $6.2 | $5.885 | 369,678 | 11-20-2024 |
| $6.03 | $5.73 | $6.03 | $6.1 | $5.55 | 506,593 | 11-19-2024 |
| $5.92 | $6.75 | $5.92 | $6.75 | $5.82 | 1,760,804 | 11-18-2024 |
| $6.75 | $7 | $6.75 | $7.15 | $6.52 | 1,945,111 | 11-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-11-30 06:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Omeros Corporation (Nasdaq: OMER) today announced an update on its progress toward planned resubmission of its biologics license application (“BLA”) for narsoplimab, the company’s first-in-class antibody targeting MASP-2, the effector enzyme of the lectin pathway of complemen...
-
Omeros Corporation (NASDAQ: OMER) is one of today's top gainers. The company's shares have moved 49.88% on the day to $6.28. Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications...